| Literature DB >> 32560317 |
Jorge Lorenzo Calvo1, Francesca Alorda-Capo2, Helios Pareja-Galeano2, Sergio L Jiménez2.
Abstract
Endurance can be defined as the capacity to maintain one's velocity or power output for the longest possible time. Maintaining such activity can lead to the onset of fatigue. Dietary nitrate supplementation produces an ergogenic effect due to the improvement of mitochondrial oxygen efficiency through a reduction in the oxygen cost of exercise that increases vasodilation and blood flow to the skeletal muscle in recreationally active subjects. However, the effects of dietary nitrate supplementation on well-trained endurance athletes remain unclear; such supplementation could affect more performance areas. In the present study, a systematic review of the literature was conducted to clarify the use and effects of nitrate as a dietary supplement in endurance athletes trained in cyclic sports (repetitive movement sports). A systematic search was carried out following the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines in the databases of SCOPUS, Web of Science (WOS), Medline (PubMed), and Sport Discus from 1 January 2010 to 30 November 2019. Twenty-seven studies were included in the study. The methodological quality of the articles was assessed using the McMaster Critical Review Form. Statistically significant ergogenic results were obtained in 8 (29.63%) of the 27 studies investigated, with significant results obtained for cardiorespiratory parameters and performance measures. Improvement in exercise tolerance was obtained, which could help with exhaustion over time, while the improvement in exercise economics was not as clear. Additionally, the dose necessary for this ergogenic effect seems to have a direct relationship with the physical condition of the athlete. The acute dose is around 6-12.4 mmol/day of nitrate administered 2-3 h before the activity, with the same amount given as a chronic dose over 6-15 days. Further studies are required to understand the factors that affect the potential ergogenic impacts of nitrate on athletic performance among endurance athletes.Entities:
Keywords: beetroot juice; cyclic; endurance; nitrate; nitric oxide; performance exercise
Mesh:
Substances:
Year: 2020 PMID: 32560317 PMCID: PMC7353291 DOI: 10.3390/nu12061796
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1The main beneficial effects of nitric oxide on physical performance.
Classification of vegetables according to nitrate content *.
| Nitrate Content (mg/100 g Fresh Weight) | Vegetable Varieties |
|---|---|
| Very low, <20 | Artichoke, asparagus, broad bean, eggplant, garlic, onion, green bean, mushroom, pea, pepper, potato, summer squash, sweet potato, tomato, watermelon |
| Low, 20 to <50 | Broccoli, carrot, cauliflower, cucumber, pumpkin, chicory |
| Middle, 50 to <100 | Cabbage, dill, turnip, savoy cabbage |
| High, 100 to <250 | Celeriac, Chinese cabbage, endive, fennel, kohlrabi, leek, parsley |
| Very high, >250 | Celery, cress, chervil, lettuce, red beetroot, spinach, rocket |
* Information obtained from Hord et al. 2009 [4].
Methodological quality of the studies included in the systematic review.
| Reference | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | Ts | % | MQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balsalobre et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Bescós et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 14 | 93.3 | VG |
| Bescós et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 14 | 93.3 | VG |
| Boorsma et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Callahan et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 13 | 86.6 | VG |
| Cermak et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Cermak et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 13 | 86.6 | VG |
| Christense et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Esen et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Garnacho et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Glaister et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Hoon et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Hoon et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Lane et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 14 | 93.3 | VG |
| Lansley et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Lowings et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| MacLeod et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| McQuillan et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| McQuillan et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Nyakayiru et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Nybäck et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Pawlak et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 13 | 86.6 | VG |
| Peacock et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Pinna et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Rokkedal et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Shannon et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
| Wilkerson et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 15 | 100 | VG |
Ts—Total items fulfilled by study; 1—Criterion met; 0—Criterion not met; MQ—Methodological quality: P—poor ≤ 8 points, A—acceptable 9–10 points, G—good 11–12 points, VG—very good 13–15 points.
Figure 2Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) flow. Summary of the systematic search and the study selection process.
Summary of studies reviewed examining the effects of nitrate supplementation on trained athletes of cyclic endurance performance.
| Reference | Participants | Age | Sports Experience and/or Training Load | VO2max (mL/kg/min) | Supplementation Protocol | Nitrate Dose (mmol/day) | Last Dose (hours) | Exercise Protocol | Principal Performance Measures | Results |
|---|---|---|---|---|---|---|---|---|---|---|
| Balsalobre et al. [ | M, middle and long-distance runners ( | 26.3 | International athletes with personal bests | 71.8 | BJ 70 mL (15 days) | 6.5 | 24 | Incremental running test to exhaustion | Time (s), RPE, SmO2 (%), VO2 (mL/kg/min) | Time (S: 1269 |
| Bescós et al. [ | M, cyclists and triathletes ( | 32.6 | Experience in endurance events: 8 | 60 | Sodium nitrate 250 mL (3 days) | 11.6 | 3 | Distance trial (40 min) in cycle ergometer | Distance covered (km), Mean power output (W), VO2 (mL/kg/min) | Distance covered (S: 26.4 |
| Bescós et al. [ | M, cyclists and triathletes ( | 34.3 | Members of competitive squads | 65.1 | Sodium nitrate 250 mL (1 day) | 11.8 | 3 | Submaximal cycling trial (4 × 6 min) (T1), incremental exercise test to exhaustion (T2) | T1: VO2 (L/min) at 3.5 W/kg | T1: VO2 (S: 0.5 |
| Boorsma et al. [ | M, distance runners ( | 23.8 | Elite distance; | 80 | BJ 210 mL (1 day) | 19.5 | 1.5 | Submaximal treadmill run (T1), time trial 1500 m (T2) | T1: VO2 (mL/min) T2: time (s) | T1: VO2 (S: 4192 |
| BJ 210 mL (on the test day) and 140 (other days) (8 days) | 19.5 and 13 | 2.5 | Submaximal treadmill run (T1), time trial 1500 m (T2) | T1: VO2 (mL/min) T2: time (s) | T1: VO2 (S: 4299 | |||||
| Callahan et al. [ | M, cyclists ( | 34 | Well-trained cyclist | 65.2 | Beetroot crystals 15 g (3 days) | 5 | 1 | Time trial 4 km | Mean power output (W), time (s) | Mean power output (S: 388 |
| Cermak et al. [ | M, cyclists and triathletes ( | 31 | Training history of ≈10 years, | 58 | BJ 140 mL (6 days) | 8 | 2.5 | Submaximal cycling trail (2 × 30 min) (P1), time trial 10 km (T2) | T1: VO2 (L/min) | T1: VO2 (S: 2.94 |
| Cermak et al. [ | M, cyclists and triathletes ( | 26 | Training experience: >3 times/wk for several years | 60 | BJ 140 mL (1 day) | 8.7 | 2.5 | Time trial ≈1 h | Mean power output (W), time (min) | Mean power output (S: 275 |
| Christensen et al. [ | M, cyclists ( | 29 | Experience: elite cyclists competing at the highest domestic level | 72.1 | BJ 500 mL (6 days) | 8 | 3 | Submaximal cycling trial at 70% Wmax (2 × 6 min) (T1), repeated sprint test (6 × 20 s) (T2), time trial 400 kcal (≈20 min) (T3) | T1: VO2 (mL/min) | P1: VO2 (S: 792 |
| Esen et al. [ | M ( | 22 | Experience: ≥10 years competing at club standard and ≥5 years competing in regional and university-level. | 2212 | BJ 140 mL (3 days) | 8 | 3 | Time trial 200 m (T1), | T1: time (s) | T1: time (S: 152.6 |
| Garnacho et al. [ | M, triathletes ( | 39.3 | Experience: National ( | 54.8 | BJ 70 mL (1 day) | 6.5 | 3 | Time trial at VT1 (30 min) and VT2 (15 min) | VO2 (L/min), VCO2 (L/min), time (s) at VT2 | VO2 (S: 73.8 |
| Glaister et al. [ | F, cyclists and triathletes ( | 31 | Experience: ≈13 years actively in sport; training volume: 10.7 | 52.3 | BJ 70 mL (1 day) | 7.3 | 2.5 | Time trial 20 km | Time (min) | Time (S: 35.33 |
| Hoon et al. [ | M, cyclists ( | 20.3 | Trained male cyclists that were involved in a 6 week training camp at the Australian Institute of Sport | - | BJ 70 mL (1 day) | 4.1 | 1.25 | Time trail 4 min ×2 | Mean power output (W) | Mean power output (S: 403 |
| 2.5 | Time trail 4 min ×2 | Mean power output (W) | Mean power output (S: 402 | |||||||
| Hoon et al. [ | M, rowers ( | 20.6 | Highly trained; 2000-m personal-best time: 6 min, 17 s | - | BJ 70 mL (1 day) | 4.2 | 2 | Time trial 2000 m | Time (s) | Time (S: 383.4 |
| BJ 140 mL (1 day) | 8.4 | 2 | Time trial 2000 m | Time (s) | Time (S: 381.9 | |||||
| Lane et al. [ | M ( | 31 | Competitive level | 71.6 | BJ 140 mL (1 day) | 8.4 | 2 | Time trial 43.83 km | Time (min), power output (W) | Time (S: 64 |
| 28 | Competitive level | 59.9 | BJ 140 mL (1 day) | 8.4 | 2 | Time trial 29.35 km | Time (min), power output (W) | Time ( | ||
| Lansley et al. [ | M, cyclists ( | 21 | Competitive level | 56 | BJ 500 mL (1 day) | 6.2 | 2.5 | Time trial 4 km | Time (min), mean power output (W), VO2 (L/min) | Time (S: 6.27 |
| Time trial 16.1 km | Time (min), mean power output (W), VO2 (L/min) | Time (S: 26.9 | ||||||||
| Lowings et al. [ | M ( | 20 | Competitive level; training volume: ≥3 times/wk | − | BJ 140 mL (1 day) | 12.5 | 3 | Time trial 168 m | Time (s) | Time ( |
| MacLeod et al. [ | M, cyclists ( | 29.3 | Trained cyclists that met the inclusion criterion VO2peak > 5 L/min | 67.5 | BJ 70 mL (1 day) | 6.5 | 2 | Time trial 15 km | Time (s), mean power output (W/kg) | Time (S: 961 |
| McQuillan et al. [ | M, cyclists ( | 27 | Endurance trained cyclists and competing in cycle races in the 3 months preceding the study; training volume: regular 11.4 | 68 | BJ 140 mL (3 days) | 8 | 2.5 | Time trial 4 km | Time (s), mean power output (W) | Time (S: 341 |
| BJ 140 mL (4 days) | 8 | 2.5 | Time trial 1 km | Time (s), mean power output (W) | Time (S: 79.6 | |||||
| BJ 140 mL (6 days) | 8 | 2.5 | Time trial 4 km | Time (s), mean power output (W) | Time (S: 340 | |||||
| BJ 140 mL (7 days) | 8 | 2.5 | Time trial 1 km | Time (s), mean power output (W) | Time (S: 79.3 | |||||
| McQuillan et al. [ | M, cyclists ( | 26 | Well-trained endurance cyclists; | 63 | BJ 70 mL (8 days) | 4 | 2 | Time trial 4 km | Time (s), mean power output (W) | Time (S: 343.6 |
| Nyakayiru et al. [ | M, cyclists and triathletes ( | 25 | Competitive cyclist; | 65 | Sodium nitrate 1097 mg (1 day) | 12.9 | 4 | Submaximal cycling trial at 45% Wmax (30 min) and 65% Wmax (30 min) (T1), time trial 10km (T2), | T1: VO2 | T1: VO2 (D = no) |
| Sodium nitrate 1097 mg (6 days) | 12.9 | 4 | submaximal cycling trial at 45% Wmax (30 min) and 65% Wmax (30min) (T1), time trial 10km (T2) | T1: VO2 | T1: VO2 (D = no) | |||||
| Nybäck et al. [ | M ( | 21.8 | Well-trained, competing at a national level | 71.5 | BJ 140 mL (1 day) | 13 | 2.5 | Submaximal test (2 × 6 min) (T1), time trial 1 km (T2) | T1: VO2 (L/min) T2: time (s) | T1: VO2 (S: 2.92 |
| Pawlak et al. [ | M, triathletes and runners ( | 21.7 | Runners from clubs engaged in intense endurance exercise training and competition; inclusion based on VO2max > 65 mL/kg/min | 71.1 | BJ 500 mL (3 days) | 5.4 | 3 | Repeated sprint test to exhaustion | No. of sprints completed, mean power output (W), VO2 (mL/min) | No. of sprints completed (S: 13.9 |
| Peacock et al. [ | M, cross-country skiers ( | 18 | Experience: national and international standard junior skiers, all among the 20 best in the 2010 Norwegian Cup Series; training history: 502 ± 45 h/year | 69.6 | Potassium nitrate | 9.9 | 2.5 | Submaximal test at 55% VO2max (5 min) and 75% VO2max (5 min) (T1), time trial 5 km (T2) | T1: VO2 (L/min) | T1: VO2 (S: 3.77 |
| Pinna et al. [ | M, swimmers ( | 34.7 | Master athletes involved in regional and national competitions; training volume: average of 6.5 | 42.7 | BJ 500 mL (6 days) | 5.5 | 3 | Incremental swimming test | Workload (kg/min), VO2 (mL/min) | Workload (S: 6.7 |
| Rokkedal et al. [ | M, cyclists ( | 29.1 | Well-trained in performance level 4 [ | 66.4 | BJ 140 mL (7 days) | 12.4 | 2.75 | Time trial 10 km | Power output (W), time (s), VO2 (mL/min) | Power output (S: 315.8 |
| Shannon et al. [ | M, runners and triathletes ( | 28.3 | Experience in competing in running events | 62.3 | BJ 140 mL (1 day) | 12.5 | 3 | Time trial 1500 m | Time (s), VO2 (mL/kg/min) | Time (S: 319.6 |
| Time trial 10 km | Time (s), VO2 (mL/kg/min) | Time (S: 2643.1 | ||||||||
| Wilkerson et al. [ | M, cyclists ( | 31 | Well-trained subjects; | 63 | BJ 500 mL (1 day) | 6.2 | 2.5 | Time trial 50 miles | Time (min), mean power output (W) | Time (S: 136.7 |
M: male, F: female, VO2max: maximal oxygen uptake, VO2peak: peak oxygen uptake, BJ: beetroot juice, SmO2: vastus lateralis oxygen saturation, RPE: rating of perceived exertion, VCO2: expired carbon dioxide, D: statistical difference, T: trial, VT: ventilatory threshold, PLA: placebo, S: supplemented.
Summary table with studies on the cyclic endurance performance of trained athletes.
| Sport |
| Sex | Number of Studies | Number of Significant Studies | Results on Respiratory and/or Performance Parameters | |
|---|---|---|---|---|---|---|
| Performance | Respiratory | |||||
| Cycling | 101 | All M | 9 | 2 [ | Time [ | VO2max [ |
| Cycling and Triathlon | 97 | 85 M, 12 F | 6 | 2 [ | Time [ | VO2peak [ |
| Athletics and Triathlon | 17 | All M | 2 | 1 [ | Time, RPE | SmO2 |
| Triathlon | 26 | 12 M, 14 F | 2 | |||
| Athletics | 20 | All M | 2 | 1 [ | Time | |
| Cross-country skiing | 18 | 15 M, 3 F | 2 | |||
| Rowing | 10 | All M | 1 | 1 [ | Time | |
| Swimming | 34 | 24 M, 10 F | 3 | 1 [ | Time | Reduction of aerobic energy cost |
| Six different sports | 323 | Only one study exclusively with F [ | 27 | 8 | 7 | 5 |
M: male, F: female, VO2max: maximal oxygen uptake, VO2peak: peak oxygen uptake, SmO2: vastus lateralis oxygen saturation, RPE: rating of perceived exertion, MPO: mean power output.